✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Halozyme Therapeutics Inc

Common Name
Halozyme Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
423
Ticker
HALO
Exchange
NASDAQ/NGS
Description
Halozyme Therapeutics Inc. is a biopharmaceutical company that researches, develops, and commercializes proprietary enzymes and drug delivery technologies. Its core platform centers on the patented re...

Disclosures of Halozyme Therapeutics

Explore Halozyme Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Halozyme Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of Halozyme Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20244 disclosures
10-K
en
ESG Data Spreadsheet
en
ESG Report
en
Financial & Extra-Financial Disclosure
en
20232 disclosures
10-K
en
ESG Report
en
20222 disclosures
ESG Report
en
10-K
en
20212 disclosures
10-K
en
ESG Report
en
20201 disclosure
10-K
en
20191 disclosure
10-K
en
20181 disclosure
10-K
en
20171 disclosure
10-K
en
20161 disclosure
10-K
en
20151 disclosure
10-K
en
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?